"Hopp holds 80 percent of the shares in CureVac through its Dievini Hopp BioTech Holding. The second largest shareholder is the Bill and Melinda Gates Foundation, which, together with CureVac, develops vaccines against a range of infectious diseases. "I am committed to the goal of protecting all people from infections and to better treat and cure patients worldwide and in the best case, as well as my intention to create sustainable innovative infrastructure and jobs in Germany," said Hopp."
And I had to edit...I put "major" shareholder, but the foundation is actually the 2nd largest shareholder.
In this article: https://www.manager-magazin.de/unternehmen/artikel/curevac-donald-trump-lockt-tuebinge-impfstoff-firma-und-forscher-in-usa-a-1305445.html, search for "Gates", then pull that paragraph out for a Google translate.
It says:
"Hopp holds 80 percent of the shares in CureVac through its Dievini Hopp BioTech Holding. The second largest shareholder is the Bill and Melinda Gates Foundation, which, together with CureVac, develops vaccines against a range of infectious diseases. "I am committed to the goal of protecting all people from infections and to better treat and cure patients worldwide and in the best case, as well as my intention to create sustainable innovative infrastructure and jobs in Germany," said Hopp."